Skip to main content
Equibles
PTGX logo

PTGX · Protagonist Therapeutics, Inc · Webcasts, Transcripts & Audio

Track PTGX — free

Use PTGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PTGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$140.06 +0.87 (+0.63%) At close · Oct 2
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$9.18B
Shares
64.71M
Volume · Oct 2 760.3K Avg daily vol (3M) 634.39K

Protagonist Therapeutics, Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Protagonist Therapeutics, Inc (PTGX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲15.6% $2.72M −$17.50M '19 Q4 20-03-10 ▲184.4% $170.64M $131.67M '24 Q4 25-02-21 ▼88.9% $28.32M −$11.65M '25 Q1 25-05-06 ▲33.1% $5.55M −$34.77M '25 Q2 25-08-06 LATEST ▲3749.2% $213.47M $162.85M '26 Q2 26-08-05
Conference
Investor event
2026-09-10
Protagonist Therapeutics, Inc (PTGX) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Capital Markets Day
Investor event
2026-09-08
Protagonist Therapeutics, Inc (PTGX) September 2026 Capital Markets Day
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
Protagonist Therapeutics, Inc (PTGX) Q2 2026 Earnings Call
Revenue
$213.47M
▲ 3749.2% YoY
Diluted EPS
$2.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Protagonist Therapeutics, Inc (PTGX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-12
Protagonist Therapeutics, Inc (PTGX) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-08-06
Protagonist Therapeutics, Inc (PTGX) Q2 2025 Earnings Call
Revenue
$5.55M
▲ 33.1% YoY
Diluted EPS
$-0.55
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Protagonist Therapeutics, Inc (PTGX) Q1 2025 Earnings Call
Revenue
$28.32M
▼ 88.9% YoY
Diluted EPS
$-0.19
▼ 105.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-21
Protagonist Therapeutics, Inc (PTGX) Q4 2024 Earnings Call
Revenue
$170.64M*
▲ 184.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-03-10
Protagonist Therapeutics, Inc (PTGX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q1
2020-05-07
Protagonist Therapeutics, Inc (PTGX) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Protagonist Therapeutics, Inc (PTGX) Q4 2019 Earnings Call
Revenue
$2.72M
▲ 15.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–11 of 11 webcasts
Key facts CIK 1377121 CUSIP 74366E102 13F (30d) 8 filings 8 filers Visit website Investor relations